SCHEMBL212565

SCHEMBL212565

CC(=O)ON=C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
FAAH O00519 1/20 0.50
ABHD16A O95870 1/20 0.50
KMT2A Q03164 1/20 0.50
PLA2G7 Q13093 1/20 0.50
NCEH1 Q6PIU2 1/20 0.50
DAGLB Q8NCG7 1/20 0.50
DAGLA Q9Y4D2 1/20 0.50
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.44
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
KDM4E B2RXH2 4/20 0.35
RXFP1 Q9HBX9 1/20 0.34
ESR1 P03372 1/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213364 1.00 MEN1 (0.50) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL212465 1.00 MEN1 (0.50) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL214510 1.00 MEN1 (0.50) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL215531 1.00 MEN1 (0.50) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL212464 0.98 RAB9A (0.47) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL2045395 0.88 RAB9A (0.38) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL2044667 0.84 RAB9A (0.38) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL2044665 0.84 RAB9A (0.38) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL9900514 0.80 RAB9A (0.34) MEN1FAAHABHD16AKMT2APLA2G7
SCHEMBL9010403 0.79 MEN1 (0.45) MEN1FAAHABHD16AKMT2APLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077941-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2012-03-29 US claimed
US-8088868-B2 oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis BRIDGESTONE CORPORATION (JP) 2012-01-03 US claimed
US-20080146745-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2008-06-19 US claimed
JP-11189578-A None JP disclosed
CN-114349702-A Method for synthesizing N-acetyl caprolactam by using continuous flow microchannel reactor 中石化南京化工研究院有限公司 2022-04-15 CN disclosed
US-20200399204-A1 PHOTO ACTIVATOR AND MANUFACTURING METHOD OF THE SAME AND PHOTO ALIGNMENT AGENT INCLUDING THE SAME HONGIK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2020-12-24 US disclosed
US-10287419-B2 Rubber composition and vulcanization aid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-05-14 US disclosed
US-20170130028-A1 RUBBER COMPOSITION AND VULCANIZATION AID SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-11 US disclosed
US-20170130028-A1 RUBBER COMPOSITION AND VULCANIZATION AID SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-11 US disclosed
CN-104557526-A Method for preparing ortho-methylcyclohexyl acetate under solvent-free conditions ZHEJIANG JINKE PEROXIDES CO LTD 2015-04-29 CN disclosed
US-20150099800-A1 NOVEL LIPASE INHIBITORS, REPORTER SUBSTRATES AND USES THEREOF NIH - DEITR 2015-04-09 US disclosed
US-8088868-B2 oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis BRIDGESTONE CORPORATION (JP) 2012-01-03 US disclosed
US-20080146745-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS BRIDGESTONE CORPORATION (JP) 2008-06-19 US disclosed
EP-0926135-B1 Processes for producing alpha-aminonitrile derivatives and alpha-amino acids DAICEL CHEM (JP) 2002-06-05 EP disclosed
US-6365398-B1 REACTING RACEMIC CARBOXYLIC ACID ESTER WITH RACEMIC ALCOHOL IN PRESENCE OF A CARBOXYL ESTER HYDROLASE BASF AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
US-6111128-A IN THE PRESENCE OF A METAL CATALYST, REACTING AN ENOL ESTER OF GIVEN FORMULA OR OXIME ESTER WITH A CARBONYL COMPOUND AND CYANOGENATION AGENT TO FORM AN ALPHA-CYANOHYDRIN ESTER WHICH IS HYDROLYZED TO FORM ALPHA-HYDROXY ACIDS; EFFICIENCY DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-29 US disclosed
US-6100419-A Processes for producing α-aminonitrile derivatives and α-amino acids DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
JP-H11189578-A ALPHA-AMINONNITRILE DERIVATIVE AND PRODUCTION OF ALPHA-AMINO ACID DAICEL CHEM IND LTD 1999-07-13 JP disclosed
EP-0926135-A2 Processes for producing alpha-aminonitrile derivatives and alpha-amino acids Daicel Chemical Industries, Ltd. (JP) 1999-06-30 EP disclosed
EP-0926134-A2 Processes for producing alpha-cyanohydrin esters and alpha-hydroxy acids Daicel Chemical Industries, Ltd. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099800-A1 NOVEL LIPASE INHIBITORS, REPORTER SUBSTRATES AND USES THEREOF PNLIP, LIPE, LIPC MEN1 4500/4885FAAH 44/4885ABHD16A 12/4885
US-10287419-B2 Rubber composition and vulcanization aid CCNA1, RCN1, RER1 MEN1 2054/4885FAAH 2403/4885ABHD16A 3946/4885
US-20170130028-A1 RUBBER COMPOSITION AND VULCANIZATION AID CCNA1, RCN1, RER1 MEN1 2054/4885FAAH 2403/4885ABHD16A 3946/4885
US-20200399204-A1 PHOTO ACTIVATOR AND MANUFACTURING METHOD OF THE SAME AND PHOTO ALIGNMENT AGENT INCLUDING THE SAME MOK, PPOX, CCNO MEN1 3835/4885FAAH 752/4885ABHD16A 1998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.